Therapeutic Delivery

Scope & Guideline

Transforming Therapeutics Through Open Access Knowledge

Introduction

Delve into the academic richness of Therapeutic Delivery with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2041-5990
PublisherNewlands Press Ltd
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2010 to 2024
AbbreviationTHER DELIV / Ther. Deliv.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2 Albert Pl, London N3 1QB, UNITED KINGDOM

Aims and Scopes

The journal 'Therapeutic Delivery' focuses on advancing the field of drug delivery systems through innovative research and comprehensive reviews. The main aims and scopes encompass a variety of methodologies and applications that address the challenges in therapeutic delivery across multiple diseases.
  1. Nanotechnology in Drug Delivery:
    A significant emphasis on the utilization of nanotechnology to enhance drug delivery systems, including nanocarriers, nanomedicines, and nanoemulsions, aimed at improving bioavailability and targeting specific sites in the body.
  2. Targeted and Controlled Release Systems:
    Research dedicated to developing targeted delivery mechanisms that allow for controlled release of therapeutics, thereby maximizing efficacy while minimizing side effects, particularly in cancer and chronic diseases.
  3. Innovative Formulation Strategies:
    Exploration of novel formulation techniques, such as microemulsions, liposomes, and hydrogels, to optimize the delivery of pharmaceuticals, ensuring stability and improved therapeutic outcomes.
  4. Therapeutics for Diverse Diseases:
    A broad scope that includes the development of drug delivery systems for various diseases, including cancer, neurodegenerative disorders, infectious diseases, and metabolic conditions.
  5. Quality by Design (QbD) Approaches:
    Incorporating QbD principles into the formulation and development of drug delivery systems to ensure consistent quality and performance of therapeutics.
Recent publications in 'Therapeutic Delivery' show a clear trajectory towards emerging themes and trending topics that reflect the current needs and advancements in the field of drug delivery. These themes are gaining traction and are indicative of future research directions.
  1. Gene Therapy and RNA Delivery Systems:
    An increasing focus on the development of delivery systems for nucleic acids, including siRNA and gene therapy approaches, suggests a trend towards leveraging genetic interventions in treatment protocols.
  2. Personalized Medicine Applications:
    Research is trending towards personalized drug delivery systems tailored to individual patient profiles, particularly in oncology, which enhances therapeutic efficacy and minimizes adverse effects.
  3. Sustainable and Green Formulations:
    Emerging interest in sustainable drug delivery methods, including biodegradable materials and eco-friendly formulations, aligns with global trends towards environmental responsibility in pharmaceutical development.
  4. Advanced Targeting Techniques:
    Innovations in targeting mechanisms, such as the use of aptamers and antibodies for specific cellular targeting, are increasingly prevalent, showcasing a shift towards precision medicine.
  5. Combination Therapies and Multi-Drug Delivery Systems:
    There is a rising trend in research focused on combination therapies utilizing multi-drug delivery systems, particularly for complex diseases like cancer, to enhance treatment outcomes.

Declining or Waning

As the field of drug delivery evolves, certain themes within 'Therapeutic Delivery' appear to be diminishing in frequency or prominence. This section highlights these waning areas, reflecting the journal's shifting focus.
  1. Traditional Drug Delivery Methods:
    There is a noticeable decline in publications focused on conventional drug delivery methods, as the journal increasingly highlights advanced technologies and innovative formulations that offer enhanced efficacy.
  2. Non-targeted Systems:
    Papers discussing non-targeted drug delivery systems are less frequent, indicating a shift towards more sophisticated, targeted approaches that improve therapeutic outcomes.
  3. General Reviews without Novel Insights:
    There is a waning interest in general review articles that do not present new data or insights, with a preference now for studies that provide innovative methodologies or significant advancements in the field.

Similar Journals

ADVANCED DRUG DELIVERY REVIEWS

Exploring Innovations in Drug Delivery.
Publisher: ELSEVIERISSN: 0169-409XFrequency: 12 issues/year

ADVANCED DRUG DELIVERY REVIEWS, published by ELSEVIER, is a leading journal in the field of pharmaceutical sciences, particularly acclaimed for its contributions to the disciplines of pharmacology, toxicology, and pharmaceutics. With an impressive 2023 Scopus rank of #1 out of 183 in its category, this journal is situated in the Q1 quartile, reflecting its high impact and the relevance of its published research. Since its inception in 1987, it has continually focused on the latest advancements in drug delivery systems, making it an indispensable resource for researchers, professionals, and students interested in the innovative developments that shape the pharmaceutical landscape. The journal aims to publish comprehensive and authoritative reviews that foster a deeper understanding of drug delivery mechanisms, technologies, and their clinical applications. Although it operates under a subscription model, the value it provides through rigorous peer-reviewed content ensures it remains an essential tool for anyone seeking to enhance their knowledge in this rapidly evolving field.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Advancing pharmaceutical sciences through rigorous research.
Publisher: ELSEVIERISSN: 0939-6411Frequency: 9 issues/year

European Journal of Pharmaceutics and Biopharmaceutics is a leading academic journal published by Elsevier, dedicated to advancing the field of pharmaceutical sciences through high-quality research. Established in 1991, this multidisciplinary journal offers a platform for the dissemination of innovative findings in pharmaceutics and biopharmaceutics, covering crucial aspects such as drug formulation, delivery systems, and the interface of pharmaceutical formulation with biological systems. The journal is well-regarded for its impact, earning a Q1 status in Pharmaceutical Science and consistent Q2 rankings in both Biotechnology and Medicine (Miscellaneous) categories in 2023, thereby highlighting its significance in the scientific community. With an impressive Scopus ranking of 26th percentile in Pharmaceutical Science and 60th percentile in Biotechnology, it positions itself firmly at the forefront of research, supporting researchers, professionals, and students in their quest to address complex health challenges. While the journal does not offer an open-access option, it facilitates a rigorous peer-review process, ensuring that published articles meet the highest standards of scientific integrity. For those looking to make meaningful contributions to the field, the European Journal of Pharmaceutics and Biopharmaceutics serves as an essential resource and reference point.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Pioneering Innovations in Drug Development and Delivery
Publisher: ELSEVIERISSN: 0928-0987Frequency: 15 issues/year

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

Biomaterials Research

Exploring new horizons in biomaterials science.
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 1226-4601Frequency: 1 issue/year

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

JOURNAL OF CONTROLLED RELEASE

Advancing drug delivery through innovative research.
Publisher: ELSEVIERISSN: 0168-3659Frequency: 24 issues/year

JOURNAL OF CONTROLLED RELEASE is a premier academic journal published by Elsevier that is dedicated to advancing the field of pharmaceutical science with a focus on drug delivery systems. Established in 1984, the journal has consistently served as a vital platform for disseminating high-quality research and innovative ideas in the area of controlled release technologies. With an impressive impact factor and ranking in the Q1 category of Pharmaceutical Science, it ranks #3 out of 183 in Scopus for its field, reflecting its influence and significance within the academic community, as noted by its percentile of 98th. The journal encompasses a wide range of topics, including polymer science, pharmacokinetics, and bioengineering, ensuring it remains at the forefront of pharmaceutical advancements. While currently not offering open access options, the journal serves a diverse audience of researchers, professionals, and students who are eager to push the boundaries of knowledge in drug delivery and therapeutics. For those looking to make impactful contributions in this dynamic field, JOURNAL OF CONTROLLED RELEASE is an essential resource for both foundational studies and cutting-edge research findings.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Unveiling Breakthroughs in Pharmaceutical Science
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

AAPS PHARMSCITECH

Delivering Cutting-edge Insights for Public Health Advancements
Publisher: SPRINGERISSN: 1530-9932Frequency: 1 issue/year

AAPS PHARMSCITECH is a prestigious peer-reviewed journal published by Springer, focusing on the dynamic field of pharmaceutical sciences and technology. With an ISSN of 1530-9932, it provides a vital platform for disseminating cutting-edge research that spans key areas including drug discovery, pharmacology, toxicology, and ecological impacts of pharmaceuticals. The journal is recognized for its rigorous scientific contributions, currently holding a commendable Q2 quartile ranking across several relevant categories, including Agronomy and Crop Science, Aquatic Science, and Medicine in 2023. Notably, it ranks 43rd out of 183 in the Scopus Pharmacology, Toxicology, and Pharmaceutics category, placing it in the 76th percentile of its field. Aiming to foster innovation and collaboration among researchers, professionals, and students, AAPS PHARMSCITECH is committed to advancing scientific knowledge and addressing contemporary challenges in pharmaceutical sciences. The journal offers various access options to ensure wide dissemination of research findings, making it an essential resource for those dedicated to enhancing public health through pharmaceutical advancements.

Asian Journal of Pharmaceutical Sciences

Elevating the standards of pharmaceutical research worldwide.
Publisher: SHENYANG PHARMACEUTICAL UNIVISSN: 1818-0876Frequency: 6 issues/year

Asian Journal of Pharmaceutical Sciences is a prestigious open-access journal published by Shenyang Pharmaceutical University, dedicated to advancing research and developments in the field of pharmaceutical sciences. Since its inception in 2009, the journal has successfully converged a wealth of knowledge and innovation, demonstrating an impressive track record with its open access model adopted in 2013, ensuring global dissemination of crucial research findings. With an outstanding impact factor and consistently ranked in the Q1 category for both Pharmaceutical Science and Pharmacology in 2023, it ranks among the top journals in its field, as evidenced by its impressive Scopus rankings—4th out of 183 in Pharmaceutical Science and 10th out of 313 in Pharmacology, showcasing its high relevance and credibility (98th and 96th percentiles respectively). Researchers, professionals, and students can access a diverse array of articles that encompass groundbreaking studies, reviews, and reports, solidifying the journal's position as a vital resource for anyone engaged in pharmaceutical research. With its commitment to quality and accessibility, Asian Journal of Pharmaceutical Sciences plays an essential role in fostering innovation and collaboration within the global scientific community.

JOURNAL OF MICROENCAPSULATION

Fostering Collaboration for Advancements in Microencapsulation
Publisher: TAYLOR & FRANCIS LTDISSN: 0265-2048Frequency: 8 issues/year

Welcome to the JOURNAL OF MICROENCAPSULATION, a leading academic publication devoted to the multifaceted applications and advancements in the fields of microencapsulation technology. Published by Taylor & Francis Ltd in the United Kingdom, this journal has been at the forefront of research since 1984, providing a platform for the dissemination of innovative studies encompassing bioengineering, organic chemistry, and pharmaceutical sciences, among other disciplines. With a commendable impact factor, the journal holds impressive rankings in its respective categories, including a Q2 status in Pharmaceutical Science and Physical and Theoretical Chemistry as of 2023. The JOURNAL OF MICROENCAPSULATION is committed to advancing knowledge through rigorous peer-reviewed articles, fostering collaboration among researchers, professionals, and students. While it operates under a traditional access model, it ensures that cutting-edge research reaches a broad readership, underscoring its significance in enhancing the understanding of microencapsulation processes and their applications across various industries.

Journal of Pharmaceutical Investigation

Exploring the forefront of pharmaceutical sciences for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 2093-5552Frequency: 6 issues/year

Journal of Pharmaceutical Investigation, published by SPRINGERNATURE, is a leading academic resource in the field of pharmaceutical sciences, offering critical insights and innovative research findings. With an impact factor that underscores its significance, this journal ranks in the Q1 category for both Pharmacology and Pharmaceutical Science as of 2023, showcasing its high-quality publications and rigorous peer-review processes. Operating from the Netherlands, the journal spans from 2012 to 2024, offering a rich archive of interdisciplinary research contributions that advance knowledge in pharmacology, toxicology, and pharmaceutics. It holds impressive Scopus rankings, placing it among the top-tier journals in its categories, which enhances its appeal to researchers, professionals, and students aiming to publish their work or stay up-to-date with the latest advancements in the pharmaceutical field. Engaging with the Journal of Pharmaceutical Investigation not only enriches your understanding but also connects you with a community dedicated to advancing healthcare and therapeutic innovations.